Ahmad Alhammouri, MD
Interventional Cardiology · Jeffersonville, INNPI 1124260385
Payments from drug & device makers
Across 882 payments — averaging $100.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk AS$83K
- Edwards Lifesciences$1K
- AstraZeneca$818
- Boston Scientific$481
- Cardiovascular Systems Inc.$382
- Inari Medical, Inc.$309
- plus $2K from 29 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk AS | 688 | $82,894 |
| Edwards Lifesciences | 14 | $1,126 |
| AstraZeneca | 30 | $818 |
| Boston Scientific | 19 | $481 |
| Cardiovascular Systems Inc. | 16 | $382 |
| Inari Medical, Inc. | 6 | $309 |
| Novartis | 17 | $285 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 14 | $217 |
| Heartflow, Inc. | 4 | $207 |
| Johnson & Johnson | 12 | $192 |
| Amgen | 11 | $188 |
| Merck | 5 | $174 |
| Abbott | 7 | $169 |
| Abiomed | 5 | $143 |
| W. L. Gore & Associates, Inc. | 1 | $140 |
| Penumbra, Inc. | 1 | $124 |
| Medtronic(2 entities) | 5 | $114 |
| Sanofi-aventis U.S. LLC | 5 | $101 |
| Pfizer | 4 | $60 |
| Stryker | 2 | $47 |
| Chiesi USA, Inc. | 1 | $44 |
| Boehringer Ingelheim | 2 | $42 |
| Terumo Medical Corporation | 1 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
| Teleflex LLC | 1 | $23 |
| Philips North America LLC | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Lexicon Pharmaceuticals, Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $17 |
| Actelion Pharmaceuticals US, Inc. | 1 | $16 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| United Therapeutics Corporation | 1 | $14 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Angiodynamics, Inc. | 1 | $13 |
| Esperion Therapeutics, Inc. | 1 | $12 |
How this compares
$88,489 in reported general payments places this provider in the 85th percentile of 170 interventional cardiology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Jeffersonville
- James HermillerIndianapolis$2.8M
- Jithendra ChoudaryRichmond$1.6M
- Jeffrey BreallIndianapolis$955K
- Samer AbbasEast Chicago$625K
- Jarrod FrizzellEvansville$559K
- Brian BigelowIndianapolis$444K
- Saeed ShaikhIndianapolis$366K
- Dean FerreraEast Chicago$298K
- Woodrow CoreyIndianapolis$262K
- Navneet LatherNoblesville$223K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.